A Comprehensive Review on Tuberculosis

Issue

Vol. 13 No. 2 (2025): 2025 Volume -13 - Issue 2

Date Log

Published
April 9, 2025
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

A Comprehensive Review on Tuberculosis

https://doi.org/10.61096/ijamscr.v13.iss2.2025.152-155
Mohd Hussain Wani
Student at Mewar University, Chittorgarh, Rajasthan, India
Kulbir Singh
Student at Mewar University, Chittorgarh, Rajasthan, India
Tamheed Zahid
Student at Mewar University, Chittorgarh, Rajasthan, India
Shubam Singh
Student, Deen Dayal Rustagi College of Pharmacy, Haileymandi, Haryana, India
Tanya Sharma
Assistant Professor, Mewar Universty, Chittorgarh, Rajasthan, India

International Journal of Allied Medical Sciences and Clinical Research, Vol. 13 No. 2 (2025): 2025 Volume -13 - Issue 2

Abstract

Tuberculosis (TB) remains a global public health challenge, affecting millions of people annually. Despite advancements in diagnostics and therapeutics, the disease continues to be a leading cause of mortality, particularly in low- and middle-income countries. TB is a complex infectious disease that requires a multidisciplinary approach for effective control. This review explores the epidemiology, pathophysiology, clinical manifestations, diagnostic methods, and treatment strategies for TB. Emphasis is placed on recent advancements in molecular diagnostics, novel therapeutic approaches, and the impact of socio-economic factors on disease spread. Furthermore, the review highlights the challenges in TB control, including drug resistance, vaccine development, and the role of public health interventions in combating the disease.

Keywords

Tuberculosis, Mycobacterium tuberculosis, Drug resistance, Diagnosis, Epidemiology, Treatment strategies, Public health, Molecular diagnostics.
1.
Mohd Hussain Wani, Kulbir Singh, Tamheed Zahid, Shubam Singh, Tanya Sharma. A Comprehensive Review on Tuberculosis. Int. J. of Allied Med. Sci. and Clin. Res. [Internet]. 2025 Apr. 9 [cited 2026 Feb. 27];13(2):152-5. Available from: https://ijamscr.com/ijamscr/article/view/1599
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. World Health Organization. Global Tuberculosis Report 2021.
  2. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57-72.
  3. WHO. Tuberculosis: Key Facts. 2021.
  4. Esmail H, et al. The ongoing challenge of latent tuberculosis. New Engl J Med. 2018;379(14):1356-1366.
  5. Dheda K, et al. The epidemiology of tuberculosis. Clin Chest Med. 2019;40(4):653-677.
  6. Pai M, et al. Tuberculosis diagnostics: Challenges and opportunities. Microbiol Spectr. 2017;5(1):TNMI7-0030-2016.
  7. Nahid P, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines. Clin Infect Dis. 2016;63(7):e147-e195.
  8. Udwadia ZF, et al. Multidrug-resistant tuberculosis in India. Lancet Infect Dis. 2012;12(1):28-40.
  9. Gygli SM, et al. Resistance in Mycobacterium tuberculosis: Molecular mechanisms and clinical implications. Clin Microbiol Rev. 2017;30(4):887-920.
  10. Lange C, et al. Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. J Intern Med. 2018;284(2):163-188.
  11. Nahid P, Dorman SE, Alipanah N. Executive summary: Official ATS/CDC/IDSA clinical practice guidelines. Clin Infect Dis. 2016;63(7):853-867.
  12. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2015;19(11):1276-1287.
  13. Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642-1656.
  14. McShane H. Tuberculosis vaccines: Beyond BCG. Philos Trans R Soc Lond B Biol Sci. 2015;370(1671):20140306.
  15. Lönnroth K, et al. Towards tuberculosis elimination: An action framework for low-incidence countries. Eur Respir J. 2015;45(4):928-952.
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 554 Download : 200